Table 3. Proportion of pneumococcal disease syndromes potentially preventable by PCV formulation, among children < 5 years of age in Mozambique.

	PCV10		PCV13
	n/N	%	n/N	%
Overall	383/588	65	488/588	83
Clinical syndromes
Bacteraemic pneumonia	247/375	66	310/375	83
Bacteraemia (non-pneumonia)	105/165	64	141/165	85
Pneumococcal Meningitis	31/48	65	37/48	77
Age group
0–11 months	166/263	63	210/263	80
12–23 months	118/187	63	159/187	85
24–59 months	99/138	72	119/138	86